Pawar Neal

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pawar Neal's trades of Enfusion Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-05
US Enfusion Inc (ENFN)
S Sale
7,609 +26.6%
442.98
US$642,477 		7,609 +26.6% 442.98 US$642,477
2025-03-05 2025-03-05
US Enfusion Inc (ENFN)
PrS Proposed sale
64,684
455.20
US$4,016,264 		64,684 455.20 US$4,016,264
2025-03-05 2025-03-03
US Enfusion Inc (ENFN)
S Sale
45,061 +29.7%
467.36
US$740,465 		45,061 +29.7% 467.36 US$740,465
2025-03-03 2025-03-03
US Enfusion Inc (ENFN)
PrS Proposed sale
2,769
11.48
US$31,792 		2,769 11.48 US$31,792
2024-12-04 2024-12-03
US Enfusion Inc (ENFN)
S Sale
26,246 -2.3%
10.09
US$264,822 		26,246 -2.3% 10.09 US$264,822
2024-12-03 2024-12-03
US Enfusion Inc (ENFN)
PrS Proposed sale
26,246
10.09
US$264,814 		26,246 10.09 US$264,814
2024-12-04 2024-12-02
US Enfusion Inc (ENFN)
S Sale
21,801 -1.9%
10.03
US$218,664 		21,801 -1.9% 10.03 US$218,664
2024-12-02 2024-12-02
US Enfusion Inc (ENFN)
PrS Proposed sale
21,560
10.03
US$216,193 		21,560 10.03 US$216,193
2024-12-02 2024-11-29
US Enfusion Inc (ENFN)
S Sale
19,226 -1.6%
9.92
US$190,722 		19,226 -1.6% 9.92 US$190,722
2024-11-29 2024-11-29
US Enfusion Inc (ENFN)
PrS Proposed sale
19,226
9.92
US$190,712 		19,226 9.92 US$190,712